Nelly Etienne-Selloum Selected Research

Nelly Etienne-Selloum Research Topics

Disease

13	Neoplasms (Cancer) 01/2023 - 03/2010
5	Glioblastoma (Glioblastoma Multiforme) 09/2022 - 03/2021
5	Hypertension (High Blood Pressure) 07/2011 - 01/2008
3	Squamous Cell Carcinoma of Head and Neck 01/2023 - 06/2019
3	Glioma (Gliomas) 03/2021 - 01/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 07/2011 - 01/2010
2	Coronary Disease (Coronary Heart Disease) 05/2009 - 01/2008
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Breast Neoplasms (Breast Cancer) 11/2020
1	Carcinogenesis 11/2020
1	Oncogene Addiction 06/2019
1	Brain Neoplasms (Brain Tumor) 09/2016
1	Wounds and Injuries (Trauma) 07/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2012
1	Leukemia 01/2012
1	Teratocarcinoma 04/2011
1	Heart Diseases (Heart Disease) 12/2010
1	Cardiomegaly (Heart Hypertrophy) 12/2010
1	Carcinoma (Carcinomatosis) 09/2010
1	Aberrant Crypt Foci 09/2010
1	Neoplasm Metastasis (Metastasis) 09/2010
1	Hypoxia (Hypoxemia) 05/2009
1	Vascular Diseases (Vascular Disease) 01/2008

Drug/Important Bio-Agent (IBA)

9	PolyphenolsIBA 01/2012 - 01/2008
7	IntegrinsIBA 09/2022 - 01/2016
3	Cetuximab (Erbitux)FDA Link 01/2023 - 06/2019
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 06/2021
3	Angiotensin IIIBA 12/2010 - 01/2008
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2010 - 01/2008
2	LigandsIBA 01/2023 - 01/2021
2	SolventsIBA 06/2021 - 09/2010
2	Tyrosine Kinase InhibitorsIBA 03/2021 - 06/2019
2	Gefitinib (Iressa)FDA Link 03/2021 - 06/2019
2	Caspase 3 (Caspase-3)IBA 01/2012 - 09/2010
2	TeaIBA 07/2011 - 01/2010
1	Rituximab (Mabthera)FDA Link 05/2023
1	obinutuzumabIBA 05/2023
1	IronIBA 01/2023
1	EpiregulinIBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	Cell Surface ReceptorsIBA 09/2022
1	Nucleic AcidsIBA 09/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	Proteins (Proteins, Gene)FDA Link 08/2021
1	Caveolin 1IBA 06/2021
1	Integrin alpha5beta1IBA 03/2021
1	Integrin alpha5IBA 03/2021
1	Peptides (Polypeptides)IBA 01/2021
1	PeptidomimeticsIBA 01/2021
1	Endocrine DisruptorsIBA 11/2020
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 06/2019
1	human ERBB2 proteinIBA 06/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2019
1	ErbB Receptors (EGF Receptor)IBA 06/2019
1	AfatinibIBA 06/2019
1	Monoclonal AntibodiesIBA 06/2019
1	CateninsIBA 09/2016
1	beta CateninIBA 09/2016
1	Fibronectins (Fibronectin)IBA 01/2016
1	erucylphosphocholineIBA 07/2014
1	CaspasesIBA 01/2012
1	Cyclin B1IBA 01/2012
1	UbiquitinIBA 04/2011
1	diethylstilbestrol monophosphate (PDES)IBA 12/2010
1	Cyclic NucleotidesIBA 12/2010
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 12/2010
1	Matrix Metalloproteinases (MMPs)IBA 09/2010
1	Cyclin-Dependent Kinase Inhibitor p16IBA 09/2010
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2010
1	Cyclin D1IBA 09/2010
1	Drinking WaterIBA 09/2010
1	AzoxymethaneIBA 09/2010
1	Acetylcholine (Acetylcholine Chloride)FDA Link 04/2010
1	Arginine (L-Arginine)FDA Link 04/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2009
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 05/2009

Therapy/Procedure

6	Therapeutics 01/2023 - 09/2016
4	Drug Therapy (Chemotherapy) 05/2023 - 09/2016
2	Radiotherapy 06/2021 - 04/2021
1	Adjuvant Radiotherapy 06/2021
1	Immunotherapy 04/2021
1	Mediterranean Diet 01/2010